Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
35,033
archived clinical trials in
Lung Cancer

A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Texas Oncology - Sherman
mi
from
Sherman, TX
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Texas Oncology - Sherman
mi
from
Sherman, TX
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Providence Regional Medical Center Everett
mi
from
Everett, WA
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Providence Regional Medical Center Everett
mi
from
Everett, WA
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Cancer Care Northwest
mi
from
Spokane Valley, WA
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Cancer Care Northwest
mi
from
Spokane Valley, WA
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Northwest Medical Specialties
mi
from
Tacoma, WA
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Northwest Medical Specialties
mi
from
Tacoma, WA
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Mary Babb Cancer Center
mi
from
Morgantown, WV
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Mary Babb Cancer Center
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Green Bay Oncology
mi
from
Green Bay, WI
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Green Bay Oncology
mi
from
Green Bay, WI
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Green Bay Oncology, Ltd. - St. Mary's Site
mi
from
Green Bay, WI
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Green Bay Oncology, Ltd. - St. Mary's Site
mi
from
Green Bay, WI
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Palm Beach Cancer Institute, LLC
mi
from
West Palm Beach, FL
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Palm Beach Cancer Institute, LLC
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Emory University/Winship Cancer Institute
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated:  11/3/2015
Landesklinikum Krems
mi
from
Krems,
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
A Randomized, Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced Non-Small-Cell Lung Adenocarcinoma
Status: Enrolling
Updated: 11/3/2015
Landesklinikum Krems
mi
from
Krems,
Click here to add this to my saved trials
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated:  11/3/2015
Aurora St. Luke's Hospital
mi
from
Milwaukee, WI
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated: 11/3/2015
Aurora St. Luke's Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated:  11/3/2015
Aurora West Allis
mi
from
West Allis, WI
Effect of Cancer Nurse Navigators on Patient Outcomes
Pilot Test of the Effect of Cancer Nurse Navigators on Patient Outcomes
Status: Enrolling
Updated: 11/3/2015
Aurora West Allis
mi
from
West Allis, WI
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Tucson, AZ
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Santa Monica, CA
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Atlanta, GA
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Chicago, IL
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceutials Investigative Site
mi
from
Boston, MA
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceutials Investigative Site
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Winston-Salem, NC
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Kettering, OH
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Kettering, OH
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Portland, OR
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Portland, OR
Click here to add this to my saved trials
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated:  11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Brussels,
Study of Ganetespib (STA-9090) + Docetaxel in Advanced Non Small Cell Lung Cancer
A Randomized, Phase IIB/III Study of Ganetespib (STA-9090) in Combination With Docetaxel Versus Docetaxel Alone in Subjects With Stage IIIb or IV Non-Small-Cell Lung Cancer
Status: Enrolling
Updated: 11/4/2015
Synta Pharmaceuticals Investigative Site
mi
from
Brussels,
Click here to add this to my saved trials
Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Palliative Care for Quality of Life and Symptom Concerns in Late Stage Lung Cancer
Status: Enrolling
Updated:  11/4/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Effects of Palliative Care on Quality of Life and Symptom Control in Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
Palliative Care for Quality of Life and Symptom Concerns in Late Stage Lung Cancer
Status: Enrolling
Updated: 11/4/2015
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Reader Study of DeltaView™ Chest Radiograph Software
Reader Study to Demonstrate That Use of DeltaView™ is Superior to the Use Standard Prior and Current Antero/Posterior (AP/PA) X-ray Image Pair
Status: Enrolling
Updated:  11/4/2015
ISIS Research Center, Georgetown University Medical Center
mi
from
Washington,
Reader Study of DeltaView™ Chest Radiograph Software
Reader Study to Demonstrate That Use of DeltaView™ is Superior to the Use Standard Prior and Current Antero/Posterior (AP/PA) X-ray Image Pair
Status: Enrolling
Updated: 11/4/2015
ISIS Research Center, Georgetown University Medical Center
mi
from
Washington,
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Northeast Arkansas Clinic
mi
from
Jonesboro, AR
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Northeast Arkansas Clinic
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Florida Cancer Specialists
mi
from
Fort Myers, FL
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Florida Cancer Specialists
mi
from
Fort Myers, FL
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Medical Oncology Associates of Augusta
mi
from
Augusta, GA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Medical Oncology Associates of Augusta
mi
from
Augusta, GA
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Baptist Hospital East
mi
from
Louisville, KY
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Baptist Hospital East
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Norton Cancer Institute
mi
from
Louisville, KY
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Norton Cancer Institute
mi
from
Louisville, KY
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Hematology Oncology Clinic, LLP
mi
from
Baton Rouge, LA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Hematology Oncology Clinic, LLP
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
National Capital Clinical Research Consortium
mi
from
Bethesda, MD
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
National Capital Clinical Research Consortium
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Research Medical Center
mi
from
Kansas City, MO
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Oncology Hematology Care
mi
from
Cincinnati, OH
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Oncology Hematology Care
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
South Carolina Oncology Associates, PA
mi
from
Columbia, SC
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Chattanooga Oncology Hematology Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
The Family Cancer Center
mi
from
Collierville, TN
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
The Family Cancer Center
mi
from
Collierville, TN
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Tennessee Oncology, PLLC
mi
from
Nashville, TN
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Peninsula Cancer Institute
mi
from
Newport News, VA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Peninsula Cancer Institute
mi
from
Newport News, VA
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Virginia Cancer Institute
mi
from
Richmond, VA
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Virginia Cancer Institute
mi
from
Richmond, VA
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Watson Clinic Center for Cancer Care and Research
mi
from
Lakeland, FL
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Watson Clinic Center for Cancer Care and Research
mi
from
Lakeland, FL
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Florida Hospital Cancer Institute
mi
from
Orlando, FL
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Florida Hospital Cancer Institute
mi
from
Orlando, FL
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Grand Rapids Clinical Oncology Program
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated:  11/6/2015
Nebraska Methodist Cancer Center
mi
from
Omaha, NE
A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
A Phase II Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer
Status: Enrolling
Updated: 11/6/2015
Nebraska Methodist Cancer Center
mi
from
Omaha, NE
Click here to add this to my saved trials
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)
A Phase I Study of Intensity Modulated Radiotherapy (IMRT) for Malignant Pleural Mesothelioma After Radical Pleurectomy/Decortication (PD)
Status: Enrolling
Updated:  11/9/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Radical Pleurectomy/Decortication (PD) and Intensity Modulated Radiotherapy (IMRT)
A Phase I Study of Intensity Modulated Radiotherapy (IMRT) for Malignant Pleural Mesothelioma After Radical Pleurectomy/Decortication (PD)
Status: Enrolling
Updated: 11/9/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
A Phase Ib, Open-label, Dose Escalation Trial Investigating Different Doses and Schedules of Sym004 in Combination With Platinum-doublets in Subjects With Stage IV Non-small Cell Lung Cancer
Status: Enrolling
Updated:  11/9/2015
Please Contact U.S. Medical Information Located in
mi
from
Rockland, MA
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
A Phase Ib, Open-label, Dose Escalation Trial Investigating Different Doses and Schedules of Sym004 in Combination With Platinum-doublets in Subjects With Stage IV Non-small Cell Lung Cancer
Status: Enrolling
Updated: 11/9/2015
Please Contact U.S. Medical Information Located in
mi
from
Rockland, MA
Click here to add this to my saved trials
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
A Phase Ib, Open-label, Dose Escalation Trial Investigating Different Doses and Schedules of Sym004 in Combination With Platinum-doublets in Subjects With Stage IV Non-small Cell Lung Cancer
Status: Enrolling
Updated:  11/9/2015
Please contact the Merck KGaA Communication Center Located in
mi
from
Darmstadt,
Sym004 in Subjects With Stage IV Non-small Cell Lung Cancer
A Phase Ib, Open-label, Dose Escalation Trial Investigating Different Doses and Schedules of Sym004 in Combination With Platinum-doublets in Subjects With Stage IV Non-small Cell Lung Cancer
Status: Enrolling
Updated: 11/9/2015
Please contact the Merck KGaA Communication Center Located in
mi
from
Darmstadt,
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
The University of California, San Diego
mi
from
La Jolla, CA
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
The University of California, San Diego
mi
from
La Jolla, CA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
UCLA Med-Hematology & Oncology
mi
from
Los Angeles, CA
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
UCLA Med-Hematology & Oncology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated:  11/13/2015
University of California at San Francisco
mi
from
San Francisco, CA
An Efficacy Study of MORAb-009 (Amatuximab) in Subjects With Pleural Mesothelioma
An Open-Label Clinical Trial of MORAb-009 in Combination With Pemetrexed and Cisplatin in Subjects With Mesothelioma
Status: Enrolling
Updated: 11/13/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials